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Summary
 
Cellular immunity against 
 
Mycobacterium tuberculosis
 
 controls infection in the majority of in-
fected humans. Studies in mice have delineated an important role for CD4
 
1
 
 T cells and cyto-
kines including interferon 
 
g
 
 and tumor necrosis factor 
 
a
 
 in the response to infection with myco-
bacteria. Recently, the identification of CD8
 
1
 
 CD1-restricted T cells that kill 
 
M
 
.
 
 tuberculosis
 
organisms via granulysin and the rapid death after infection of 
 
b
 
2 microglobulin deficient mice
in humans has drawn attention to a critical role for CD8
 
1
 
 T cells. The nature of mycobacterial-
specific CD8
 
1
 
 T cells has been an enigma because few have been identified in any species.
Here, we delineate the contribution of class I MHC–restricted T cells in the defense against tuber-
culosis as transporter associated with antigen processing (TAP)1-deficient mice died rapidly, bore
a greater bacterial burden, and had more severe tissue pathology than control mice. In contrast,
CD1D
 
2/2
 
 mice were not significantly different in their susceptibility to infection than control
mice. This data demonstrates a critical role for TAP-dependent peptide antigen presentation and
provides further evidence that class I MHC–restricted CD8
 
1
 
 T cells, the major T cell subset
activated by this antigen processing pathway, play an essential role in immunity to tuberculosis.
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Mycobacterium tuberculosis
 
T
 
uberculosis is the most common cause of death from
an infectious pathogen in the world (1). The caus-
ative agent, 
 
Mycobacterium tuberculosis
 
,
 
 
 
infects and grows intra-
cellularly in macrophages, induces an intense immune
response, and leads to the development of caseating
granulomas, the pathological hallmark of the disease. It is
well established that CD4
 
1
 
 T cells are critical in the im-
mune response to 
 
M
 
.
 
 tuberculosis
 
 in rodents and humans.
This may be a consequence of the intracellular compart-
mentalization of 
 
M
 
.
 
 tuberculosis
 
 in the phagolysosome,
which could favor entry of its proteins into the class II
MHC antigen-processing pathway (2).
The participation of CD8
 
1
 
 T cells in immunity to 
 
M
 
.
 
 tuber-
culosis
 
 is less clearly defined. Prior studies using antibody
mediated T cell subset depletion (3) and adoptive transfer of
purified T cell subsets (4–6) were able to show that CD8
 
1
 
T cells could reduce CFU of 
 
M
 
.
 
 tuberculosis
 
 in the spleen of
infected mice, although the effect was consistently weaker
than that observed for CD4
 
1
 
 T cells (3, 4). Infection of mice
with the less virulent 
 
Mycobacterium bovis
 
 (Bacillus Calmette-
Guerin, BCG) consistently found that CD8
 
1
 
 T cells made
no contribution to immunity (7–9). This difference between
the immune response to 
 
M
 
.
 
 tuberculosis
 
 and 
 
M
 
.
 
 bovis
 
 BCG
may be a reflection of their differing virulences. However,
none of these studies examined the immune response in the
lung, the site where rodents fail to control the infection af-
ter intravenous infection, nor were any other variables ex-
amined, such as pathology or survival. Furthermore, it has
been difficult even to demonstrate the presence of myco-
bacterial-specific CD8
 
1
 
 T cells in human tuberculosis pa-
tients until recently (10, 11). Given the relative lack of data
implicating CD8
 
1
 
 T cells in immunity to
 
 M
 
.
 
 tuberculosis
 
, it
was a remarkable finding that mice genetically deficient in
 
b
 
2 microglobulin (
 
b
 
2m),
 
1
 
 and as a consequence lacking in
CD8
 
1
 
 T cells, were unable to control infection, particu-
larly in the lung, and succumbed prematurely to tubercu-
losis (12). Although the susceptible phenotype observed in
 
b
 
2m-deficient mice was thought to be secondary to the
 
1
 
Abbreviations used in this paper:
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b
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b
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ulin; ER, endoplasmic reticulum; MST, mean survival time; TAP, trans-
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loss of class I MHC–restricted CD8
 
1
 
 T cells, 
 
b
 
2m is also a
component of a number of other antigen-presenting mole-
cules, including H2-M3, TL, Qa-1, Qa-2, and CD1d. Be-
cause the MHC-encoded class I, H2-M3, Qa-1, and Qa-2
molecules have all been shown to bind peptide antigens
loaded in a transporter-associated with antigen processing
(TAP)-dependent fashion, whereas CD1 molecules, includ-
ing CD1d, are characterized to bind lipid-based antigens,
we sought to discriminate these pathways.
The CD1 family of 
 
b
 
2m-associated, non-MHC locus–
encoded proteins are able to present hydrophobic lipids and
glycolipids to T cells. Specifically, the human group 1 CD1
proteins (CD1a, -b, and -c) have been shown to present
mycobacterial antigens such as mycolic acid, glucose mono-
mycolate, and lipoarabinomannan to human 
 
a/b
 
-TCR
 
1
 
 T
cells (13–15). The mouse has a pair of CD1 genes that are
likely to represent a recent duplication, and are homolo-
gous to the human group 2 CD1 protein CD1d. Phos-
phatidylinositol-containing compounds have been eluted
from murine CD1d (16), and both murine and human CD1d
can present the glycolipid 
 
a
 
-galactosylphytosphingosine to
T cells in a TAP-independent manner (17, 18). The ability
of murine CD1d to bind glycolipids that are structurally
similar to CD1-restricted mycobacterial antigens, together
with the delineation of CD1d-restricted T cells that use a
diverse TCR repertoire (19–21), led us to hypothesize that
CD1d may also be capable of presenting mycobacterial an-
tigens to murine T cells.
In contrast to the presentation of lipid antigens by CD1,
class I MHC presents peptides to CD8
 
1
 
 T cells. The class I
MHC antigen-processing pathway is dependent upon cleav-
age and processing of protein antigens (by the proteosome),
followed by transport of the peptides from the cytosol into
the endoplasmic reticulum (ER) by the TAP complex. Here,
the processed peptides associate with the class I MHC and
 
b
 
2m proteins to form a trimeric complex (22). The TAP
protein is a heterodimer of the 
 
tap1
 
 and 
 
tap2
 
 gene products,
and mediates the translocation of peptides from the cyto-
plasm into the ER. Cells that are deficient in either TAP1
or TAP2 are unable to efficiently process peptides derived
from cytosolic proteins by the class I MHC pathway. In
 
tap1
 
-deficient mice, this defect in the class I MHC antigen-
processing pathway results in greatly reduced numbers of
CD8
 
1
 
 T cells in all lymphoid organs, as CD8
 
1
 
 T cells are
not positively selected during T cell maturation in the
thymus (23). In contrast, TAP deficiency is not believed to
lead to a deficiency of CD1-restricted T cells, as all
examples of CD1-restricted antigen recognition by T cells
have been determined to be TAP independent (17, 24, 25).
We therefore felt that the 
 
TAP1-
 
deficient (TAP1
 
2/2
 
) and
 
CD1D
 
-deficient (CD1D
 
2/2
 
) mice would be important in-
dependent models to determine the significance of CD8
 
1
 
T cells in immunity to 
 
M
 
.
 
 tuberculosis
 
.
 
Materials and Methods
 
Mice.
 
6–8-wk-old male (129/Sv,C57BL/6) TAP1
 
2/2
 
 (26)
and control (C57BL/6 
 
3
 
 129/Sv) F1 or F2 mice were obtained
from The Jackson Laboratory. C57BL/6 
 
b
 
2m-deficient mice
(
 
b
 
2m
 
2/2
 
) and control C57BL/6 mice were also obtained from
The Jackson Laboratory. CD1D
 
2/2
 
 mice and their littermate
controls were used at the F2 and F6 backcross to C57BL/6 (27)
or the F8 backcross to BALB/c mice (28). CD1D
 
2/2
 
TAP1
 
2/2
 
mice were generated by backcrossing the CD1D
 
2/2
 
 onto the
TAP1
 
2/2
 
 background. All mice were housed in a biosafety level
3 facility under specific pathogen–free conditions at the Animal
Biohazard Containment Suite (Dana-Farber Cancer Institute,
Boston, MA) and used in a protocol approved by the institution.
 
Bacteria and Infections.
 
Virulent 
 
M. tuberculosis
 
 (Erdman strain;
originally obtained from Barry Bloom, Albert Einstein College of
Medicine, Bronx, NY) was passaged through mice and then
grown in Middlebrook 7H9 supplemented with oleic acid-
albumin-dextrose complex (OADC; Difco), before freezing ali-
quots at 
 
2
 
80
 
8
 
C. Before inoculation of mice, an aliquot was
thawed, diluted in normal saline (0.9% NaCl) containing 0.02%
Tween 80, and sonicated twice for 10 s using a cup horn soni-
cator (Branson Ultrasonics Corp.). Mice were infected intrave-
nously via the lateral tail vein with 10
 
6
 
 live bacilli. The inocu-
lum dose was confirmed by plating an aliquot onto 7H10 agar
plates (Hardy or Remel).
 
Flow Cytometry.
 
Venous blood from mice infected with
 
M
 
.
 
 tuberculosis 
 
was obtained by retro-orbital puncture. 50 
 
m
 
l of
blood anti-coagulated with heparin was stained with PE-conju-
gated anti-CD8 antibody (clone 53-6.72) (PharMingen) or a con-
trol antibody. The RBCs were lysed with NH
 
4
 
Cl and after ex-
tensive washing with buffer the samples were resuspended in 1%
paraformaldehyde-PBS and analyzed after 24 h using a FACSort™
(Becton Dickinson). The percentage of CD8
 
1
 
 T cells within the
lymphoid gate was determined.
 
CFU Determination.
 
To quantify viable mycobacteria in the
infected mouse organs, the lungs, liver, and spleen were asepti-
cally removed from each killed animal. The left lung, left lobe
of the liver, and half of the spleen were homogenized in 0.02%
Tween 80 in normal saline using Teflon homogenizers (Fischer).
10-fold serial dilutions were plated onto 7H10 agar plates and
colonies were counted after incubation for 3 wk at 37
 
8
 
C.
 
Histology.
 
Tissues for histological studies were fixed in 10%
buffered formalin and then embedded in paraffin blocks. 5-
 
m
 
m
sections were stained with hematoxylin and eosin or by the
Fite-Faraco method for acid-fast bacilli (AFB) (29).
 
Results
 
The Effect of CD1d on Survival of M. tuberculosis–infected
Mice.
 
To test the hypothesis that the increased suscepti-
bility of 
 
b
 
2m
 
2/2
 
 mice to 
 
M
 
.
 
 tuberculosis
 
 was due to the ab-
sence of CD1d-restricted T cells, mice that had both the
CD1D1 and CD1D2 genes disrupted by homologous re-
combination (CD1D
 
2/2
 
 mice) were infected with virulent
 
M
 
.
 
 tuberculosis
 
 (27). No significant difference between the
mortality of CD1D
 
2/2
 
 mice and that of their heterozygous
littermate controls was observed after intravenous infection
with 10
 
6
 
 CFU (Fig. 1 A). The median survival time (MST)
was 169 d for the CD1D
 
2/2
 
 mice and 136 d for the
CD1D1/2 mice. These CD1D2/2 mice were used after the
second backcross to C57BL/6 mice, and further studies us-
ing CD1D2/2 mice after the sixth backcross gave similar
results (data not shown). We also considered whether dele-
tion of CD1D increased the resistance of mice to infection1975 Behar et al.
with M. tuberculosis. Since both C57BL/6 and 129/Sv mice
are relatively resistant to tuberculosis, an increase in resis-
tance of CD1D2/2 mice on these genetic backgrounds
would be difficult to detect. Therefore, CD1D2/2 mice on
the susceptible BALB/c genetic background were infected.
CD1D2/2 mice backcrossed eight generations to BALB/c
mice showed no significant differences in survival com-
pared with CD1D1/1 BALB/c mice after infection with M.
tuberculosis (Fig. 1 B). Additional experiments using a higher
(3 3 106) or lower (2 3 105) inoculum did not reveal any
differences in survival (data not shown). Experiments done
in parallel demonstrated a significant reduction in survival
for b2m2/2 mice compared with b2m1/1 mice (data not
shown), as had been reported previously (12). These results
indicate that the increased mortality of b2m2/2 mice was
not due to an absence of CD1d-restricted T cells.
The Effect of TAP1 on Survival of M. tuberculosis–infected
Mice. As the absence of the CD1D1 and CD1D2 genes
did not significantly alter the survival of mice, TAP12/2
mice were infected with M. tuberculosis to independently
verify that the susceptibility of b2m2/2 mice to tuberculosis
was secondary to the absence of T cells restricted to MHC
molecules loaded in the ER in a transporter-dependent
manner. The vast majority of such T cells are class I MHC–
restricted CD81 T cells, and mice with disruption of the
TAP1 gene are known to have a profound deficiency in
CD81 T cells (26). We confirmed the loss of CD81 T cells
from peripheral blood after intravenous infection with
M. tuberculosis. We found that in infected TAP11/1 mice,
9.0 6 0.7% (mean 6 SEM) of PBLs were CD81, whereas
only 1.2 6 0.1% of PBLs were CD81 in TAP12/2 mice
(Fig. 2). These results were similar in uninfected TAP12/2
and control mice (30).
In three separate experiments, a total of 42 TAP12/2
mice and 42 control mice were infected intravenously with
106 CFU of M. tuberculosis. It is striking that the TAP12/2
mice were more vulnerable to death from infection than
were control mice (P , 0.0001 by the log-rank test) (Fig.
3). The TAP12/2 mice had a MST of 63 d, and with the
exception of one mouse all were dead by day 91 (Fig. 2). In
contrast, the MST for the control mice was .150 d (Fig.
3). The difference between the survival of the TAP12/2
and the TAP11/1 mice was highly statistically significant,
and the P values for the individual experiments were P ,
0.0001, P 5 0.0047, and P , 0.0001. These results dem-
onstrate the importance of an intact TAP-dependent pep-
tide loading antigen presentation pathway for immunity to
tuberculosis and strongly supports a critical role for class I
MHC–restricted CD81 T cells in the immune response to
M. tuberculosis.
The Survival of TAP12/2CD1D2/2 Mice after Infection with
M. tuberculosis. To exclude the possibility of a subtle
CD1d-dependent effect that was obscured in the presence
of CD81 T cells, the survival of TAP12/2CD1D2/2 mice
was compared with TAP12/2CD1D1/1 mice, on a mixed
129/Sv and C57BL/6 genetic background. No significant
difference was observed in the survival of these strains of
mice (Fig. 4). The MST was 79 d for the TAP12/2CD1D2/2
mice and 65 d for the TAP12/2CD1D1/1 mice, which was
similar to other experiments in which TAP12/2CD1D1/1
mice were infected (Fig. 3). This experiment is consistent
with the conclusion that CD1d does not contribute to a
protective immune response after intravenous inoculation
with M. tuberculosis.
The Effect of TAP1 Deficiency on Bacterial Burden. The
TAP12/2 mice were unable to control the progression of
the infection. The number of bacteria deposited in the
spleen, liver, and lungs was determined 1 d after infection
and was comparable to the numbers reported by other in-
vestigators (Fig. 5, reference 12). The ability of the mice to
limit the mycobacterial growth was studied at several time
points after infection. In all three organs examined, the
TAP12/2 mice were not able to control the infection as ef-
Figure 1. Survival of CD1D2/2 mice after infection
with  M. tuberculosis. CD1D2/2 mice on a resistant genetic
background (C57BL/6) (A) or a susceptible genetic back-
ground (BALB/c) (B) were inoculated with 106 M. tubercu-
losis intravenously. Each group contained 12–13 mice and
there were no statistically significant differences in survival
of the CD1D2/2 mice compared with CD1D1/1 mice us-
ing a Mann-Whitney test. A, P 5 0.91; B, P 5 0.95.
Figure 2. Peripheral blood
CD81 T cells in TAP12/2 mice
and controls after infection with
M. tuberculosis. 5 wk after infec-
tion, blood was obtained and
stained with a CD8-specific anti-
body. The percentage of CD81
cells in peripheral blood lym-
phocytes was determined by
flow cytometry for four mice/
group. The bar represents the
mean for each group. This dif-
ference was statistically signifi-
cant using a Mann-Whitney test
(P 5 0.0022).1976 CD81 T Cells in Tuberculosis
ficiently as the control mice (Fig. 5). For example, the
TAP12/2 mice had a 10–100-fold increase in the number
of mycobacteria isolated from the lung 10 wk after infec-
tion. Similar differences were seen in the spleen and liver.
In contrast, the early phase of the infection (days 1–21) was
similar in TAP12/2 and TAP11/1 mice (Fig. 5 and data not
shown). This result is consistent with the finding that pro-
tective CD41 T cells are present by day 10 after infection,
whereas protective CD81 T cells do not become apparent
until 3–4 wk after infection (4). These data indicate that the
absence of TAP1 affected the adaptive immune response.
We observed some variability between experiments, particu-
larly in the colony count data. We believe that this variabil-
ity arose from the use of two different batches of M. tuber-
culosis. One of the batches was more virulent than the
other. Formalin fixed sections of lung, spleen, and liver,
were stained for mycobacteria (AFB) to confirm the in-
creased bacterial burden in the TAP12/2 mice. In all tis-
sues, but most dramatically in the lung, AFB were more
abundant in tissue obtained from TAP12/2 mice compared
with TAP11/1 mice (Fig. 6, A and E). Although enumera-
tion of AFB was not done, the tissues from the TAP12/2
mice had more numerous foci containing AFB, and those
foci contained greater numbers of bacilli compared with
tissue taken from TAP11/1 mice. This is consistent with the
colony count data, and suggests that TAP12/2 mice are de-
fective in their capacity to control infectious foci.
Pathological Changes in Target Organs. The TAP12/2 mice
had a much greater degree of hepatosplenomegaly and en-
largement of the lungs compared with the control mice
(data not shown). Lung tissue examined 1 d after infection
appears normal by light microscopy and similar in both the
TAP11/1 and TAP12/2 mice (Fig. 6, B and F). 1 mo after
infection, the lungs of the TAP11/1 mice contain abundant
foci of infection containing mixed inflammatory cells and
most major blood vessels were surrounded by inflammatory
cells; however, the airspaces of the lungs were well pre-
served (Fig. 6 C). In contrast, the TAP12/2 mice had se-
vere pneumonia characterized by massive inflammatory cell
infiltrates, and severe reductions in airspace (Fig. 6 G). The
inflammatory cells were chiefly mononuclear cells, with
some areas of granulomatous inflammation where the pre-
dominant cell types were epithelioid cells and foamy mac-
rophages. By wk 7, well defined granulomas were observed
grossly. Microscopically, the lungs of the TAP11/1 mice also
had severe granulomatous pneumonia with reduction of
lung aeration (Fig. 6 D). In the TAP12/2 lungs, there was
nearly complete obliteration of the airspace by pneumonia
with spread via the large airways; neutrophilic infiltrates
and early signs of tissue necrosis were apparent (Fig. 6 H).
Figure 3. Survival of TAP12/2 mice infected with
M. tuberculosis. TAP12/2 mice or controls were infected
with 106 M. tuberculosis intravenously. The data pre-
sented are from three separate experiments and repre-
sent a total of 42 mice in each group. The survival
curves were generated using the Kaplan-Meier method
and the difference is statistically significant with a P ,
0.0001 by the log-rank test.
Figure 4. Survival of TAP12/2
CD12/2 mice infected with M.
tuberculosis. CD1D2/2TAP12/2
or CD1D1TAP12/2 littermate
controls were infected with 106
M. tuberculosis. There were no
statistically significant differences
in survival (P 5 0.95).
Figure 5. Mycobacterial burden in TAP12/2 and control mice after in-
fection. The number of CFU recovered from the lung, spleen, and liver
was determined at the time points indicated after intravenous infection
with 106 M. tuberculosis. The baseline mycobacterial inoculum was deter-
mined 24 h after infection. Each data point is the mean bacterial counts
from three to five mice 6 SEM.1977 Behar et al.
Although there were similar qualitative changes in the na-
ture of the inflammatory infiltrate in the TAP12/2 mice
compared with the control mice, the amount of cellular in-
filtrate was greater in the TAP12/2 mice at every time point.
In contrast, the infiltrate observed in the TAP11/1 mice was
more focal and was distributed primarily in a perivascular
location with better preservation of the alveolar air space
(Fig. 6 D).
A similar pattern was seen with the spleens and livers.
The spleens of the TAP12/2 animals were more disrupted,
and the spleens of both the TAP12/2 and control mice had
numerous giant cells. The livers of both types of mice had
well-defined granulomata, with a tendency for the granu-
lomas in the TAP12/2 mice to be slightly more cellular.
Discussion
Although it is clear that CD81 T cells play a critical role
in host defense against viral infections and some intracellu-
lar infections such as Toxoplasma gondii and Listeria monocy-
togenes, the role of CD81 T cells in immunity to tuberculo-
sis remains controversial despite numerous studies that have
examined this question. The 1992 study by Flynn et al. re-
dressed the role of CD81 T cells in M. tuberculosis infection
using mice deficient in b2m (12). Since b2m forms a het-
erodimer with the class I MHC heavy chain, mice deficient
in b2m lack surface expression of class I MHC molecules,
and therefore are unable to positively select CD81 T cells
during thymic T cell development. As a result such mice
are largely deficient in CD81 T cells. When b2m2/2 mice
were infected with the Erdman strain of M. tuberculosis,
they quickly succumbed to infection. Associated with the
decreased survival time was an increased mycobacterial
burden in the lungs and more severe tissue pathology com-
pared with infected b2m1/1 mice (12).
One interpretation of the increased vulnerability of the
b2m2/2 mice to M. tuberculosis is that class I MHC–restricted
CD81 T cells are critical in immunity to tuberculosis.
However, alternative explanations exist. The b2m mole-
cule forms heterodimers with molecules other than the
class I MHC heavy chain, such as class Ib MHC heavy
chains (i.e., H2-M3) and the non-MHC–encoded CD1
heavy chain, both of which are antigen-presenting molecules
that present unique bacterial antigens to T cells. H2-M3 is
Figure 6. Histopathology of the lung from TAP11/1 (A–D) and TAP12/2 (E–H) mice after infection with M. tuberculosis. Mice were killed at the indicated
times after infection, tissues were harvested, and formalin-fixed, paraffin-embedded sections were stained with Fite-Faraco stain for AFB or with the hema-
toxylin and eosin 1 d (B and F), 3 wk (A, C, E, and G), or 7 wk (D and H) after infection. Original magnification: A and E, 32,000; B–D and F–H, 3300.1978 CD81 T Cells in Tuberculosis
known to specifically present N-formylated peptides de-
rived from bacterial proteins to murine CD81 T cells (31).
CD1 is known to present antigens from M. tuberculosis and
Hemophilus influenzae to human CD81 and CD4282 T
cells. For example, human CD1b and CD1c present lipid
and glycolipid antigens that are unique to mycobacterial
species, including mycolic acid and lipoarabinomannan to
human T cells, and antigen-specific CD1-restricted human
T cells are able to lyse infected cells and kill the intracellular
mycobacteria (13, 15, 32, 33). Thus, although the b2m2/2
experiments strongly implicated a crucial role for class I
MHC–restricted CD81 T cells in immunity to M. tubercu-
losis, it is now clear that the effect of deleting b2m also
might be mediated by T cell subsets other than class I
MHC–restricted CD81 T cells. One strategy to clarify the
role of b2m-dependent T cells in immunity to tuberculosis
was to examine the susceptibility of TAP12/2 or CD1D2/2
mice to infection with M. tuberculosis. TAP12/2 mice are
largely deficient in class I MHC–restricted T cells; how-
ever, because the recognition of CD1-restricted antigens is
TAP independent, the CD1-restricted T cell populations
should be largely unaffected (34, 35). Conversely, CD1D2/2
mice have intact CD81 T cell populations.
The finding that the absence of CD1d did not affect the
outcome of M. tuberculosis infection in mice does not ex-
clude the possibility that the human CD1 proteins play an
important role in immunity to tuberculosis. Presentation of
microbial antigens to T cells has been elucidated for the
human group I CD1 proteins (i.e., CD1a, CD1b, and
CD1c), but not for CD1d, which may have a greater role
in immunoregulation (36). Furthermore, although humans
are inherently more susceptible to tuberculosis than are
mice, 95% of infected individuals develop long-lived im-
munity. If the group I CD1 proteins were to participate in
the human immune response to M. tuberculosis, evolution-
ary selection may explain why group I CD1 genes are pre-
served in the human but not the murine genome. In this
regard, it is of great interest that guinea pigs, another spe-
cies that is highly susceptible to tuberculosis, has also re-
tained the group I CD1 genes (Dascher, C.C., manuscript
in preparation). The guinea pig may be a more suitable ex-
perimental animal for investigating the role of the group I
CD1 proteins in the immune response to M. tuberculosis.
We found that TAP12/2 mice had an increased suscepti-
bility to tuberculosis that was manifested by a decreased
survival after intravenous infection, increased mycobacterial
burden in the lungs, liver, and spleen, and overall more se-
vere pathological changes in the target organs. These data
establish that antigen-processing pathways that require TAP-
dependent peptide loading are critical in the development
and maintenance of protective immunity to virulent M. tuber-
culosis. In considering the b2m-associated antigen-presenting
molecules, CD1 and TL are TAP independent (24, 37, 38).
Presentation of antigens by H2-M3 and Qa-1 can be either
TAP dependent or independent (35, 35, 37, 39). There exist
examples of antigen presentation during intracellular infec-
tion with Listeria monocytogenes that are TAP independent for
H2-M3 (39) and TAP dependent for Qa-1 (40). Qa-2 is
TAP dependent (41), and although Qa-2 can bind peptides,
T cell recognition of Qa-2 has not been demonstrated.
Therefore, the TAP-dependent antigen-processing pathway
primarily activates class I MHC–restricted CD81 T cells.
CD81 class I MHC–restricted T cells are not the only
cellular subset that is abnormal in the TAP12/2 mice. Al-
though their numbers and capacity to kill the YAC-1 cell
line are normal, the repertoire of NK cells may be altered
secondary to a change in the peptides bound by the class I
MHC molecules and the overall decreased surface expres-
sion of class I MHC (30). Likewise, there is a relative ex-
pansion of NK11 T cells in TAP12/2 mice (42), although
these cells, which require CD1d1 for their positive selec-
tion, do not appear to be critical for the long-term survival
of mice infected under the conditions used in this study.
Further work will be needed to clarify the role of CD81
T cells during M. tuberculosis infection. It appears that pro-
gression of M. tuberculosis infection in both perforin- and
fas-deficient mice is unaltered, and suggests that the cyto-
lytic function of CD81 T cells is not critical in immunity to
tuberculosis (43, 44). Other work suggests that the crucial
function of CD81 T cells is mediated by IFN-g (45). We
have found that 40–60% of the CD41 T cells in the lungs of
infected mice are primed to produce IFN-g (Chackerian,
A., and S.M. Behar, manuscript in preparation), and it re-
mains to be determined whether CD81 T cells serve a role
other than the production of IFN-g. For example, CD81
CTLs and NK cells produce granulysin, a protein found
in cytotoxic granules that has direct microbicidal action
against a variety of microorganisms (33). Granulysin does
not have activity against intracellular bacteria unless it can
gain access via a pore-forming molecule such as perforin
(33). Although perforin-deficient mice are initially able to
control mycobacterial infections (43), perforin and granu-
lysin may have a role late in infection, for example in pre-
venting recrudescence of disease.
Immunity to intracellular bacterial infections has been
shown to be a cooperative effort between the innate and
adaptive immune responses. Optimum protection against
M. tuberculosis, L. monocytogenes, and Listeria major requires
synergism between CD41 and CD81 T cells. Although the
unique roles of each T cell subset during the course of in-
fection remain to be elucidated, an understanding of these
roles is critical to the rational development of vaccines and
immunotherapeutic strategies.
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